CIK 0001501989 · Accelerated filer
CytomX Therapeutics, Inc.
Sign in to watch- Ticker
- CTMX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273521219
- Phone
- 650.515.3185
- Business address
- 151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- 4 Open-market sale Chief Business Officer sold 4,119 shares at $1.30 ($5,356)
- 4 Open-market sale CEO sold 14,601 shares at $1.30 ($18,987)
- 4 Open-market sale General Counsel sold 5,486 shares at $1.30 ($7,135)
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- 8-K Event Material agreement
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- D Other Notice of Sales of Unregistered Securities
- S-3 Offering Registration Statement
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Material agreement · Unregistered share sale
- 8-K Event Shareholder vote results
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 11 of 41 · 801 filings